sodium thiosulfate has been researched along with Dermatomyositis, Adult Type in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bahans, C; Caudron, E; Courbebaisse, M; Daudon, M; Ea, HK; Frocht, V; Goossens, J; Guigonis, V; Melchior, J; Moesch, C; Richette, P; Salle, PV; Vacquerie, V | 1 |
| Davis, MDP; Ernste, FC; Ma, JE; Wetter, DA | 1 |
| Frigerio, A; Haynes, D; Hull, C; Topham, C | 1 |
| Aggarwal, R; Arnaud, L; Barbaud, A; Chasset, F; Chizzolini, C; Francès, C; Monfort, JB; Oddis, CV; Senet, P; Traineau, H | 1 |
| Smith, GP | 1 |
| Arabshahi, B; Jones, OY; Rider, LG; Silverman, RA | 1 |
1 review(s) available for sodium thiosulfate and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature.
Topics: Calcinosis; Dermatologic Surgical Procedures; Dermatomyositis; Diltiazem; Humans; Injections, Intralesional; Physical Therapy Modalities; Randomized Controlled Trials as Topic; Rituximab; Scleroderma, Systemic; Skin Diseases; Thiosulfates; Treatment Outcome | 2020 |
5 other study(ies) available for sodium thiosulfate and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases.
Topics: Adult; Calcinosis; Chelating Agents; Dermatomyositis; Female; Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Injections, Intralesional; Magnetic Resonance Imaging; Male; Sjogren's Syndrome; Thiosulfates | 2017 |
Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012-2017.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Juvenile; Arthritis, Rheumatoid; Autoimmune Diseases; Calcinosis; Chelating Agents; Connective Tissue Diseases; Dermatomyositis; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Scleroderma, Systemic; Skin Diseases, Metabolic; Thiosulfates; Undifferentiated Connective Tissue Diseases; Young Adult | 2019 |
Linear amyopathic dermatomyositis with calcinosis cutis responsive to topical sodium thiosulfate.
Topics: Administration, Topical; Adolescent; Biopsy, Needle; Calcinosis; Chronic Disease; Dermatomyositis; Humans; Immunohistochemistry; Leg Dermatoses; Male; Skin Diseases; Thiosulfates; Treatment Outcome | 2019 |
Intradermal sodium thiosulfate for exophytic calcinosis cutis of connective tissue disease.
Topics: Adult; Calcinosis; Calcium; Chelating Agents; Dermatomyositis; Female; Humans; Injections, Intradermal; Thiosulfates | 2013 |
Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.
Topics: Abatacept; Adolescent; Anti-Inflammatory Agents; Antioxidants; Calcinosis; Chelating Agents; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunoconjugates; Immunosuppressive Agents; Skin Ulcer; Thiosulfates | 2012 |